tiprankstipranks
Kura Oncology (KURA)
NASDAQ:KURA
US Market

Kura Oncology (KURA) Income Statement

Compare
591 Followers

Kura Oncology Income Statement

Last quarter (Q4 2024), Kura Oncology's total revenue was $53.88M, an increase of 4142.76% from the same quarter last year. In Q4, Kura Oncology's net income was $-19.22M. See Kura Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 53.88M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 53.88M$ -849.00K$ -759.00K$ -558.00K$ -194.00K
Operating Expenses
$ 247.08M$ 165.80M$ 139.87M$ 131.26M$ 91.90M
Depreciation and Amortization
$ 23.70M$ 849.00K$ 759.00K$ 558.00K$ 194.00K
EBITDA
$ -169.50M$ -164.96M$ -139.11M$ -129.71M$ -91.70M
Operating Income
$ -193.19M$ -165.80M$ -140.62M$ -131.82M$ -92.09M
Other Income/Expenses
$ 21.23M$ 13.17M$ 4.03M$ 792.00K$ 2.27M
Pretax Income
$ -171.97M$ -152.63M$ -135.84M$ -130.47M$ -89.63M
Net Income
$ -173.98M$ -152.63M$ -136.07M$ -129.91M$ -89.43M
Per Share Metrics
Basic EPS
$ -2.02$ -2.08$ -2.03$ -1.96$ -1.68
Diluted EPS
$ -2.02$ -2.08$ -2.03$ -1.96$ -1.68
Weighted Average Shares Outstanding
86.16M 73.23M 66.99M 66.35M 53.08M
Weighted Average Shares Outstanding (Diluted)
86.16M 73.23M 66.99M 66.35M 53.08M
Currency in USD

Kura Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis